Evaluating the centralized purchasing policy for the treatment of hepatitis C: The Colombian CASE

Angela V Pérez1, Antonio J Trujillo2, Aurelio E Mejia3

  • 1Johns Hopkins Bloomberg School of Public Health 101 North Wolfe Street Apt 415 Baltimore MD USA.

Insights

Colombia

Area of Science:

  • Public Health
  • Health Policy
  • Pharmacoeconomics

Background:

  • High drug costs for hepatitis C impede treatment access and adherence.
  • The Colombian health care system implemented a strategy in 2017 to address this issue.

Purpose of the Study:

  • To assess the effectiveness of Colombia's centralized purchasing strategy for hepatitis C drugs.
  • Evaluate changes in drug prices, clinical outcomes, and stakeholder perspectives.

Main Methods:

  • Policy implementation assessment utilizing data from the Ministry of Health and Colombian Fund for High-Cost Diseases.
  • Analysis included price changes, clinical outcomes (cure rates), and stakeholder interviews.
  • Follow-up period: October 2017 to October 2018, with 1069 patients.

Main Results:

  • Drug prices decreased by over 90%, reducing total direct costs from $100,102,171.75 to $8,378,747.
  • A 96% cure rate was achieved among treated patients.
  • 53% of patients completed treatment and were cured within the study period.

Conclusions:

  • Colombia's centralized purchasing strategy significantly reduced hepatitis C drug costs.
  • The strategy demonstrated high effectiveness in achieving patient cures and improving cost-efficiency.
  • This model offers a scalable solution for improving access to high-cost medications.

Related Concept Videos

Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
1.9K
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
395
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
485